The Hidden Cost of Delayed Hiring in Regulated Manufacturing: A Q3 2026 Reality Check
Explores the tangible business impact of unfilled critical roles in biotech, pharma, and chemical manufacturing—production delays, compliance exposure, safety incidents, and project cost overruns. Targets operations and plant managers facing mid-year staffing gaps. Includes data on ramp-up timelines for specialized roles and ROI of proactive recruitment.
July 8, 2026